Kite Pharma, Inc. Insider Trading for July 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for July 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | M | 1.35 | 10,000 | 13,500 | 395,394 | |
| Jul 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 68.96 | 4,238 | 292,252 | 74,566 | 78.8 K to 74.6 K (-5.38 %) |
| Jul 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 68.13 | 5,762 | 392,565 | 78,804 | 84.6 K to 78.8 K (-6.81 %) |
| Jul 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Buy | M | 1.35 | 10,000 | 13,500 | 84,566 | 74.6 K to 84.6 K (+13.41 %) |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 13,542 | 230,214 | 36,458 | |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 8,625 | 6,038 | 124,125 | |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 72.92 | 4,925 | 359,131 | 999 | 5.9 K to 999 (-83.14 %) |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 72.15 | 8,416 | 607,214 | 5,924 | 14.3 K to 5.9 K (-58.69 %) |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 71.22 | 7,395 | 526,672 | 14,340 | 21.7 K to 14.3 K (-34.02 %) |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 70.34 | 1,431 | 100,657 | 21,735 | 23.2 K to 21.7 K (-6.18 %) |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 13,542 | 230,214 | 23,166 | 9.6 K to 23.2 K (+140.71 %) |
| Jul 23 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 8,625 | 6,038 | 9,624 | 999 to 9.6 K (+863.36 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 148,000 | |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 73.42 | 100 | 7,342 | 5,218 | 5.3 K to 5.2 K (-1.88 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 72.65 | 3,951 | 287,040 | 5,318 | 9.3 K to 5.3 K (-42.63 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 71.55 | 3,519 | 251,784 | 9,269 | 12.8 K to 9.3 K (-27.52 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 70.92 | 1,024 | 72,622 | 12,788 | 13.8 K to 12.8 K (-7.41 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 70.12 | 406 | 28,469 | 13,812 | 14.2 K to 13.8 K (-2.86 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Buy | M | 6.89 | 9,000 | 62,010 | 14,218 | 5.2 K to 14.2 K (+172.48 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 171,299 | |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 73.08 | 793 | 57,952 | 1,695 | 2.5 K to 1.7 K (-31.87 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 72.53 | 3,567 | 258,715 | 2,488 | 6.1 K to 2.5 K (-58.91 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 71.45 | 4,241 | 303,019 | 6,055 | 10.3 K to 6.1 K (-41.19 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 70.54 | 966 | 68,142 | 10,296 | 11.3 K to 10.3 K (-8.58 %) |
| Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | M | 0.38 | 9,000 | 3,420 | 123,000 | |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 62.82 | 2,514 | 157,929 | 1,017 | 3.5 K to 1 K (-71.20 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 62.06 | 3,177 | 197,165 | 3,531 | 6.7 K to 3.5 K (-47.36 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 61.04 | 3,309 | 201,981 | 6,708 | 10 K to 6.7 K (-33.03 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Buy | M | 0.38 | 9,000 | 3,420 | 10,017 | 1 K to 10 K (+884.96 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Option Exercise | M | 6.89 | 7,700 | 53,053 | 284,600 | |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 62.97 | 1,410 | 88,788 | 6,000 | 7.4 K to 6 K (-19.03 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 62.31 | 2,896 | 180,450 | 7,410 | 10.3 K to 7.4 K (-28.10 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 61.15 | 3,394 | 207,543 | 10,306 | 13.7 K to 10.3 K (-24.77 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Buy | M | 6.89 | 7,700 | 53,053 | 13,700 | 6 K to 13.7 K (+128.33 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 63.82 | 500 | 31,910 | 1,761,957 | 1.8 M to 1.8 M (-0.03 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 63.01 | 358,757 | 22,605,279 | 1,762,457 | 2.1 M to 1.8 M (-16.91 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 62.14 | 113,047 | 7,024,741 | 2,121,214 | 2.2 M to 2.1 M (-5.06 %) |
| Jul 02 2015 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 61.22 | 191,798 | 11,741,874 | 2,234,261 | 2.4 M to 2.2 M (-7.91 %) |
| Jul 01 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | M | 1.35 | 10,000 | 13,500 | 405,394 | |
| Jul 01 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 60.78 | 1,200 | 72,936 | 74,566 | 75.8 K to 74.6 K (-1.58 %) |
| Jul 01 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 59.98 | 5,000 | 299,900 | 75,766 | 80.8 K to 75.8 K (-6.19 %) |
| Jul 01 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 58.87 | 3,800 | 223,706 | 80,766 | 84.6 K to 80.8 K (-4.49 %) |
| Jul 01 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Buy | M | 1.35 | 10,000 | 13,500 | 84,566 | 74.6 K to 84.6 K (+13.41 %) |